Codiak Biosciences Funding: $169M Raised, Series B (2016)
Codiak Biosciences is based in Boston. It has raised $169M in total funding. Latest round: Series B.
Codiak Biosciences funding overview
Codiak Biosciences is based in Boston. Codiak Biosciences has raised $169M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2016. The round record for Codiak Biosciences runs through 2016; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Flagship Ventures, Alaska Permanent Fund, Alexandria Venture Investments, Fidelity. 5 distinct backers are named across the disclosed rounds.
Codiak Biosciences has raised $169M in total disclosed funding across the rounds on record.
Who has invested in Codiak Biosciences?
ARCH Venture Partners, Flagship Ventures, Alaska Permanent Fund, Alexandria Venture Investments, Fidelity are named among the investors backing Codiak Biosciences.
What was the latest Codiak Biosciences funding round?
The most recent disclosed round is a Series B, announced in January 2016.
Where is Codiak Biosciences based?
Codiak Biosciences is based in Boston.
When did Codiak Biosciences last raise?
The last disclosed Codiak Biosciences round closed in January 2016 at Series B.
Codiak Biosciences totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.
